AmerisourceBergen to pay $625M over illegally repackaged drugs

AmerisourceBergen and its subsidiaries have agreed to pay $625 million to resolve its civil liability to the United States under the False Claims Act for causing false claims for the drugs it repackaged to be submitted to federal health care programs.

lock iconTHIS IS MEMBERS-ONLY CONTENT. To continue reading, choose one of the options below.